Article
Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain: a photoaffinity labeling study with the bupropion analogue [(125)I]-SADU-3-72.
Department of Pharmacology and Neuroscience and the Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
Biochemistry (impact factor:
3.42).
03/2012;
51(12):2425-35.
DOI:10.1021/bi300101r
pp.2425-35
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
3-fold higher affinity
affinity site
agonist-induced desensitized state
binding site(s)
bupropion binds
distinct bupropion binding sites
endoproteinase Glu-C
extracellular end
general anesthetic
ion channel
ion channel blockers selective
limited in-gel digestion
M2-9 leucine ring
nicotinic acetylcholine receptors
pharmacologically specific photolabeling
photoreactive bupropion analogue
resting state
SADU-3-72 binds
second site
Torpedo nAChR transmembrane domain